Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
McKesson
Healthtrust
Moodys
Accenture
Cantor Fitzgerald
Federal Trade Commission
UBS
Baxter

Generated: November 12, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Favipiravir

« Back to Dashboard

US Patents for Favipiravir

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Favipiravir ➤ Sign Up Nitrogen-containing heterocyclic carboxamide derivatives or salts thereof and antiviral agents comprising the same Toyama Chemical Co., Ltd. (Tokyo, JP) ➤ Sign Up
Favipiravir ➤ Sign Up Pyrazine derivatives or salts thereof, pharmaceutical composition containing the same, and production intermediates thereof Toyama Chemical Co., Ltd. (Tokyo, JP) ➤ Sign Up
Favipiravir ➤ Sign Up Compositions and kits for treating influenza Adamas Pharmaceuticals, Inc. (Emeryville, CA) ➤ Sign Up
Favipiravir ➤ Sign Up Compositions and kits for treating influenza Adamas Pharmaceuticals, Inc. (Emeryville, CA) ➤ Sign Up
Favipiravir ➤ Sign Up Organic amine salt of 6-fluoro-3-hydroxy-2-pyrazinecarbonitrile and method for producing the same Toyama Chemical Co., Ltd. (Tokyo, JP) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Favipiravir

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Favipiravir Austria 376418 2018-08-20 ➤ Sign Up
Favipiravir Australia 5300499 2018-08-20 ➤ Sign Up
Favipiravir Australia 756635 2018-08-20 ➤ Sign Up
Favipiravir Brazil 9913097 2018-08-20 ➤ Sign Up
Favipiravir Canada 2339272 2018-08-20 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Federal Trade Commission
Chubb
Teva
Farmers Insurance
Boehringer Ingelheim
Accenture
Cantor Fitzgerald
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: